Korean J Urol.  2011 Dec;52(12):824-828.

120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity

• Choi SW
• Choi YS
• Bae WJ
• Kim SJ
• Cho HJ
• Hong SH
• Lee JY
• Hwang TK
• Kim SW

Abstract

PURPOSE
Most men with benign prostatic hyperplasia (BPH) have bothersome lower urinary tract symptoms (LUTS). This study aimed to investigate the safety and efficacy of high-performance system (HPS) laser photoselective vaporization of the prostate (PVP) for the treatment of BPH in men with detrusor underactivity (DU).
MATERIALS AND METHODS
From March 2009, 371 patients with BPH were divided into 2 groups according to the findings of preoperative urodynamic study: 239 (64.4%) patients with bladder outlet obstruction (BOO) and 132 (35.6%) patients with bladder outlet obstruction with detrusor underactivity (BOO+DU). 120 W HPS laser PVP was performed to resolve the BOO. The perioperative data and postoperative results at 1 month and 12 months, including the International Prostate Symptom Score (IPSS), maximum urinary flow (Qmax), and postvoid residual urine (PVR) values, were evaluated.
RESULTS
Compared with the preoperative parameters, significant improvements in IPSS, Qmax, and PVR were observed in each group at 1 and 12 months after the operation. In addition, IPSS, Qmax, and PVR were not significantly different between the BOO and BOO+DU groups at 1 and 12 months after the operation.
CONCLUSIONS
Surgery to relieve BOO in the patients with BPH seems to be an appropriate treatment modality regardless of the existence of DU.

Keyword

Bladder dysfunction; Laser therapy; Prostatic hyperplasia

MeSH Terms

Humans
Laser Therapy
Lower Urinary Tract Symptoms
Male
Prostate
Prostatic Hyperplasia
Urinary Bladder Neck Obstruction
Urodynamics
Volatilization

Figure

• 

  FIG. 1 Distribution of patients according to the Schäfer nomogram. The number of patients who showed weak (+) contractility was 92, the number who showed weak (-) contractility was 32, and the number who showed very weak contractility was 8. The patient group with detrusor underactivity included 132 patients.

Reference

1. Chaikin DC, Blaivas JG. Voiding dysfunction: definitions. Curr Opin Urol. 2001. 11:395–398.

2. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin North Am. 2000. 38:31–47.

3. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989. 141:243–247.

4. Doll HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol. 1992. 147:1566–1573.

5. Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology. 2003. 62:5 Suppl 2. 3–10.

6. Abrams P. Objective evaluation of bladder outlet obstruction. Br J Urol. 1995. 76:Suppl 1. 11–15.

7. Sohn JH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol. 2011. 52:178–183.

8. Kang SH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Long-term follow-up results of photoselective vaporization of the prostate with the 120 W greenlight HPS laser for treatment of benign prostatic hyperplasia. Korean J Urol. 2011. 52:260–264.

9. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005. 48:965–971.

10. Ko DW, Jeong BC, Son H. Initial experiences with a new 120 W greenlight (TM) high-power system for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia in Korea. Korean J Urol. 2009. 50:1089–1094.

11. Lee JG, Shim KS, Koh SK. Incidence of detrusor underactivity in men with prostatism older than 50 years. Korean J Urol. 1999. 40:347–352.

12. Jung YS, Hwang TK, Kim JC. The outcome and satisfaction of patients with lower urinary tract symptoms/benign prostatic hyperplasia following transurethral resection of the prostate according to urodynamic obstruction and the bladder function. Korean J Urol. 2007. 48:965–970.

13. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol. 1979. 121:640–642.

14. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004. 93:745–750.

15. Gotoh M, Yoshikawa Y, Kondo AS, Kondo A, Ono Y, Ohshima S. Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction. World J Urol. 1999. 17:274–278.

16. Oelke M, Höfner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol. 2007. 52:827–834.

17. Kang MY, Ku JH, Oh SJ. Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms. J Korean Med Sci. 2010. 25:272–275.

18. Seki N, Takei M, Yamaguchi A, Naito S. Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement. Neurourol Urodyn. 2006. 25:428–432.

19. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006. 50:969–979.

20. Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery. BJU Int. 2010. 105:1429–1433.

21. Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention. Urology. 2006. 68:312–317.

22. Park KS, Cho YS, Joo KJ. Potassium-titanyl-phosphate laser photoselective vaporization of the prostate in patients with benign prostatic hyperplasia with detrusor underactivity: influence on detrusor pressure. Korean J Urol. 2009. 50:1193–1197.